Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients [Phase 3]
Phase 3 trial comparing neoadjuvant aromatase inhibitor with ovarian suppression versus chemotherapy in premenopausal breast cancer; study t…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Multi-Media Imagery Program for Breast Cancer Patients (Phase II) [Phase 2]
Phase II clinical trial update for a multi-media imagery program in breast cancer patients; study completed.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer [Phase 3]
Phase 3 trial evaluating combination chemotherapy with or without colony-stimulating factors for breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: A Study to Evaluate Vinorelbine Plus Capecitabine Combined With Trastuzumab for HER2 Positive Patients Following Neoadjuvant Chemotherapy [Phase 2]
Phase 2 trial evaluating vinorelbine plus capecitabine with trastuzumab for HER2-positive breast cancer after neoadjuvant chemotherapy; stat…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: 12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER) [Phase 2]
A Phase 2 trial update investigating 12 weeks of docetaxel plus trastuzumab in small, node-negative, HER2-positive breast cancer (SOBER). St…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor. [Phase 2]
Phase 2 clinical trial evaluating estramustine for breast cancer progression after aromatase inhibitor therapy has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions [NA]
Clinical trial PORTAL reports patient-reported outcomes after routine treatment of atypical breast lesions; results were posted in March 202…
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo [NA]
A terminated clinical trial evaluating PET/MR imaging for surgical planning in breast cancer patients treated with neoadjuvant chemotherapy;…
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer [EARLY_Phase 1]
Early-phase trial investigating Abraxane combined with lapatinib in stage I–III breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx [Phase 1]
Phase 1 trial updating BYL719 (alpelisib) plus T-DM1 in HER2-positive metastatic breast cancer patients who progressed on trastuzumab and ta…
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors [Phase 3]
A Phase 3 clinical trial update examining how obesity affects the efficacy of endocrine therapy with aromatase inhibitors in breast cancer p…
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate [Phase 2]
Phase 2 clinical trial evaluating eribulin mesylate for brain metastases from metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy [Phase 2]
Phase 2 trial evaluating a mindfulness-based intervention for breast cancer patients undergoing chemotherapy has been completed.
-
CLINICAL_TRIALS trial_result · 2020-03-02Clinical Trial Update: Impact of the Serratus Plane Block in Pain and the Use of Opioids in Breast Surgery [Phase 4]
Phase 4 trial update evaluating the impact of serratus plane block on pain and opioid use in breast surgery.
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen [Phase 1]
Phase 1 dose-escalation study in female breast cancer patients on aromatase inhibitor or tamoxifen; results completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER) [Phase 3]
Phase 3 trial comparing adjuvant regimens in operable breast cancer (MASTER): 6 cycles of docetaxel + cyclophosphamide or ACF followed by 3 …
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study [Phase 3]
Phase 3 trial comparing individualized versus standard care to reduce chemotherapy-induced nausea and vomiting in high-risk breast cancer pa…
-
FDA approval · 2020-02-25FDA Approved: NERLYNX — Supplemental Application (Puma Biotechnology, Inc.)
FDA approved a supplemental application for Nerlynx (neratinib) filed by Puma Biotechnology. This action approves a supplemental indication …
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases [Phase 2]
Phase 2 trial update for ANG1005 in patients with breast cancer and brain metastases.
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter [Phase 2]
Phase 2 study examining valproic acid vs placebo to shorten time of indwelling pleural catheter in breast cancer; study terminated with resu…
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer [NA]
Clinical trial update on PET/CT or PET/MRI for tumor measurement in patients undergoing clinical imaging or with newly diagnosed breast canc…
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis [Phase 2]
Phase 2 trial investigating palbociclib for metastatic HER2-positive breast cancer with brain metastases; study terminated with posted resul…
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer [Phase 4]
A Phase 4 clinical trial comparing Lymphoseek to Albumin Nanocolloid in head and neck cancers, melanoma, and breast cancer is ongoing with u…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Trial of Perioperative Endocrine Therapy - Individualising Care [Phase 3]
Phase 3 trial update on perioperative endocrine therapy for individualized care in breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer [Phase 2]
A Phase 2 trial evaluating the combination of everolimus with anti-estrogen therapy in hormone-receptor-positive, HER-2 negative advanced br…